A Study to Investigate the Safety of SYHA1815 in Subjects With Unresectable Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT05105464 · UNKNOWN
Trial details
- NCT number
- NCT05105464
- Sponsor
- Shanghai Runshi Pharmaceutical Technology Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-25
- Primary completion
- 2023-09-01
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.